Publication:

Optimizing Duration of Empiric Management of Suspected Central Line-Associated Bloodstream Infections in Pediatric Intestinal Failure Patients

dash.author.emailbennetcho@gmail.com
dash.depositing.authorCho, Bennet S.
dash.embargo.terms2022-05-01
dash.embargo.until2022-05-01
dash.identifier.vireo
dash.licenseLAA
dc.contributor.authorCho, Bennet S.
dc.date.accessioned2020-09-11T16:03:18Z
dc.date.available2020-09-11T16:03:18Z
dc.date.created2020-05
dc.date.issued2020-09-11
dc.date.submitted2020
dc.description.abstractPurpose: In pediatric patients requiring long-term home parenteral nutrition (PN) due to intestinal failure (IF), central line-associated bloodstream infections (CLABSI) are potentially life-threatening illnesses. Yet, there are no evidence-based guidelines for empiric management of patients who present to the emergency department. The purpose of this study was to determine the optimal length of time for empiric management of pediatric IF patients on PN who present for suspected CLABSI. Methods: Pediatric IF patients at Boston Children’s Hospital were prospectively observed from 7/1/2015 to 6/30/2018 for presentations to the emergency department for suspected CLABSIs. The primary endpoint was time to positive blood cultures. Secondary endpoints included vital signs, exam findings, laboratory studies, and responses to a symptom survey. Results: Seventy-three patients were enrolled in the study, with 35 patients presenting for CLABSI rule-out at least once during the study period. There were 49 positive blood cultures over 128 CLABSI rule-out presentations, and the median time to positive blood cultures was 11.1 hours. The probability of a blood culture becoming positive beyond 24 hours was 2.3%. Elevated C-reactive protein and neutrophil predominance on CBC correlated with positive blood cultures. Conclusions: All blood cultures that became positive did so within 48 hours and most became positive within 24 hours (46/49). This suggests that the current 48-hour rule-out used as a standard of practice at many institutions is a safe length of time to empirically manage patients with suspected CLABSI. However, the 3 patients who had positive blood cultures beyond the 24-hour mark developed fevers over the first 24 hours of hospitalization and would not have been discharged regardless of culture results. This suggest that a 24-hour rule-out would be safe with proper risk stratification. Minimizing the time of empiric management may reduce unnecessary antibiotic exposure, nosocomial complications, healthcare costs, and the burden placed on patients and their families.
dc.description.sponsorshipScholarly Project
dc.format.mimetypeapplication/pdf
dc.identifier.citationCho, Bennet S. 2020. Optimizing Duration of Empiric Management of Suspected Central Line-Associated Bloodstream Infections in Pediatric Intestinal Failure Patients. Doctoral dissertation, Harvard Medical School.
dc.identifier.orcid0000-0002-1440-0019
dc.identifier.urihttps://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37364991*
dc.language.isoen
dc.subjectCentral line-associated blood stream infection
dc.subjectcentral venous line
dc.subjectintestinal failure
dc.subjectparenteral nutrition
dc.titleOptimizing Duration of Empiric Management of Suspected Central Line-Associated Bloodstream Infections in Pediatric Intestinal Failure Patients
dc.typeThesis or Dissertation
dc.type.materialtext
dspace.entity.typePublication
oaire.licenseConditionLAA
thesis.degree.date2020
thesis.degree.grantorHarvard Medical School
thesis.degree.grantorHarvard Medical School
thesis.degree.levelDoctoral
thesis.degree.levelDoctoral
thesis.degree.nameDoctor of Medicine
thesis.degree.nameDoctor of Medicine

Open/View Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CHO-SCHOLARLYPROJECT-2020.pdf
Size:
843.38 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
LICENSE.txt
Size:
1.73 KB
Format:
Plain Text
Description:
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: